Literature DB >> 26091037

Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.

Lukas E Dow1, Kevin P O'Rourke1,2, Janelle Simon1, Darjus F Tschaharganeh1, Johan H van Es3, Hans Clevers3, Scott W Lowe1,4.   

Abstract

The adenomatous polyposis coli (APC) tumor suppressor is mutated in the vast majority of human colorectal cancers (CRC) and leads to deregulated Wnt signaling. To determine whether Apc disruption is required for tumor maintenance, we developed a mouse model of CRC whereby Apc can be conditionally suppressed using a doxycycline-regulated shRNA. Apc suppression produces adenomas in both the small intestine and colon that, in the presence of Kras and p53 mutations, can progress to invasive carcinoma. In established tumors, Apc restoration drives rapid and widespread tumor-cell differentiation and sustained regression without relapse. Tumor regression is accompanied by the re-establishment of normal crypt-villus homeostasis, such that once aberrantly proliferating cells reacquire self-renewal and multi-lineage differentiation capability. Our study reveals that CRC cells can revert to functioning normal cells given appropriate signals and provide compelling in vivo validation of the Wnt pathway as a therapeutic target for treatment of CRC.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APC; FAP; Wnt; polyposis; shRNA; tumor regression

Mesh:

Substances:

Year:  2015        PMID: 26091037      PMCID: PMC4475279          DOI: 10.1016/j.cell.2015.05.033

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  55 in total

1.  OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells.

Authors:  Laurens G van der Flier; Andrea Haegebarth; Daniel E Stange; Marc van de Wetering; Hans Clevers
Journal:  Gastroenterology       Date:  2009-05-18       Impact factor: 22.682

2.  Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability.

Authors:  Cristina Albuquerque; Célia Baltazar; Bruno Filipe; Filipa Penha; Teresa Pereira; Ron Smits; Marília Cravo; Pedro Lage; Paulo Fidalgo; Isabel Claro; Paula Rodrigues; Isabel Veiga; José Silva Ramos; Isabel Fonseca; Carlos Nobre Leitão; Riccardo Fodde
Journal:  Genes Chromosomes Cancer       Date:  2010-08       Impact factor: 5.006

3.  Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth.

Authors:  Jo Waaler; Ondrej Machon; Jens Peter von Kries; Steven Ray Wilson; Elsa Lundenes; Doris Wedlich; Dietmar Gradl; Jan Erik Paulsen; Olga Machonova; Jennifer L Dembinski; Huyen Dinh; Stefan Krauss
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

4.  Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis.

Authors:  Joanne W Jang; Robert B Boxer; Lewis A Chodosh
Journal:  Mol Cell Biol       Date:  2006-08-14       Impact factor: 4.272

5.  Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment.

Authors:  Kenneth E Hung; Marco A Maricevich; Larissa Georgeon Richard; Wei Y Chen; Michael P Richardson; Alexandra Kunin; Roderick T Bronson; Umar Mahmood; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

6.  Genetic reconstitution of tumorigenesis in primary intestinal cells.

Authors:  Kunishige Onuma; Masako Ochiai; Kaoru Orihashi; Mami Takahashi; Toshio Imai; Hitoshi Nakagama; Yoshitaka Hippo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

7.  Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi.

Authors:  Johannes Zuber; Katherine McJunkin; Christof Fellmann; Lukas E Dow; Meredith J Taylor; Gregory J Hannon; Scott W Lowe
Journal:  Nat Biotechnol       Date:  2010-12-05       Impact factor: 54.908

8.  Stage-specific sensitivity to p53 restoration during lung cancer progression.

Authors:  David M Feldser; Kamena K Kostova; Monte M Winslow; Sarah E Taylor; Chris Cashman; Charles A Whittaker; Francisco J Sanchez-Rivera; Rebecca Resnick; Roderick Bronson; Michael T Hemann; Tyler Jacks
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962

9.  Complete deletion of Apc results in severe polyposis in mice.

Authors:  A F Cheung; A M Carter; K K Kostova; J F Woodruff; D Crowley; R T Bronson; K M Haigis; T Jacks
Journal:  Oncogene       Date:  2009-12-14       Impact factor: 9.867

10.  Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis.

Authors:  M Christie; R N Jorissen; D Mouradov; A Sakthianandeswaren; S Li; F Day; C Tsui; L Lipton; J Desai; I T Jones; S McLaughlin; R L Ward; N J Hawkins; A R Ruszkiewicz; J Moore; A W Burgess; D Busam; Q Zhao; R L Strausberg; A J Simpson; I P M Tomlinson; P Gibbs; O M Sieber
Journal:  Oncogene       Date:  2012-10-22       Impact factor: 9.867

View more
  219 in total

1.  Colorectal cancer: APC restores order.

Authors:  Sarah Seton-Rogers
Journal:  Nat Rev Cancer       Date:  2015-07-09       Impact factor: 60.716

2.  Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin.

Authors:  Shanthi Ganesh; Martin L Koser; Wendy A Cyr; Girish R Chopda; Junyan Tao; Xue Shui; Bo Ying; Dongyu Chen; Purva Pandya; Edmond Chipumuro; Zakir Siddiquee; Kevin Craig; Chengjung Lai; Henryk Dudek; Satdarshan P Monga; Weimin Wang; Bob D Brown; Marc T Abrams
Journal:  Mol Cancer Ther       Date:  2016-07-07       Impact factor: 6.261

Review 3.  Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting.

Authors:  William Hankey; Wendy L Frankel; Joanna Groden
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

4.  NUDCD1 promotes metastasis through inducing EMT and inhibiting apoptosis in colorectal cancer.

Authors:  Bin Han; Yuan-Yuan Zhang; Ke Xu; Yang Bai; Li-Hong Wan; Shi-Kun Miao; Ke-Xian Zhang; Hong-Wei Zhang; Yin Liu; Li-Ming Zhou
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

5.  SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.

Authors:  Yonghe Li; Patsy G Oliver; Wenyan Lu; Vibha Pathak; Sivaram Sridharan; Corinne E Augelli-Szafran; Donald J Buchsbaum; Mark J Suto
Journal:  Cancer Lett       Date:  2016-12-30       Impact factor: 8.679

Review 6.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

7.  Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation.

Authors:  Jatin Roper; Tuomas Tammela; Adam Akkad; Mohammad Almeqdadi; Sebastian B Santos; Tyler Jacks; Ömer H Yilmaz
Journal:  Nat Protoc       Date:  2018-01-04       Impact factor: 13.491

8.  Transcription Factor ZBP-89 Drives a Feedforward Loop of β-Catenin Expression in Colorectal Cancer.

Authors:  Bryan E Essien; Sinju Sundaresan; Ramon Ocadiz-Ruiz; Aaron Chavis; Amy C Tsao; Arthur J Tessier; Michael M Hayes; Amanda Photenhauer; Milena Saqui-Salces; Anthony J Kang; Yatrik M Shah; Balazs Győrffy; Juanita L Merchant
Journal:  Cancer Res       Date:  2016-10-10       Impact factor: 12.701

9.  G9a/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS/β-catenin pathway.

Authors:  Shih-Ting Cha; Ching-Ting Tan; Cheng-Chi Chang; Chia-Yu Chu; Wei-Jiunn Lee; Been-Zen Lin; Ming-Tsan Lin; Min-Liang Kuo
Journal:  Nat Cell Biol       Date:  2016-08-15       Impact factor: 28.824

Review 10.  Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms.

Authors:  Laura Novellasdemunt; Pedro Antas; Vivian S W Li
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-19       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.